- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Health Highlights: Jan. 29, 2014
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Aleve May be Safer for Heart Than Other NSAIDs: FDA
The pain reliever Aleve may be safer for the heart than other nonsteroidal anti-inflammatory drugs (NSAIDs), according to the U.S. Food and Drug Administration.
On Tuesday, the agency posted a review online that said naproxen — the main ingredient in Aleve and a number of generic pain killers — may pose a lower risk of heart attack and stroke than ibuprofen, which is used in Advil and Motrin, the Associated Press reported.
The review — which suggested that products with naproxen should be relabeled to highlight their heart safety — was prompted by the release last year of an analysis that looked at 350,000 people taking different types of pain relievers. It concluded that naproxen does not carry the same heart risks as other NSAIDs.
The FDA review was released ahead of next week’s meeting of a panel of outside experts who will discuss the new data and recommend whether naproxen should be relabeled, the AP reported. The FDA typically follows the advice of its expert panels.
—–
Food Bacteria Toxin May be Linked to MS: Study
A poison created by bacteria in food may be a trigger for the autoimmune disease multiple sclerosis, according to a new study.
A toxin produced by the bacterium Clostridium perfringens seems to attack the same cells that are damaged in people with MS, according to researchers at Weill Cornell Medical College, NBC News reported.
“What we’ve shown is the toxins target the cells that are targeted in MS,” researcher Jennifer Linden said. She’s presenting the findings Tuesday at an American Society for Microbiology meeting.
C. perfringens causes a million cases of food poisoning in the United States each year. The researchers analyzed a small number of food products and found that about 13 percent of them contained C. perfringens, and nearly three percent tested positive for the toxin that may be linked to MS.
While it’s too soon to suggest that food poisoning may cause MS, the study does raise the possibility that C. perfringens might play a role in activating the disease, Bruce Bebo, associate vice president of discovery research for the National Multiple Sclerosis Society, told NBC News.
About 400,000 Americans have MS.
—–
Shortage of Saline IV Bags a Problem for U.S. Hospitals
There’s a shortage of saline IV bags across the United States, according to federal health officials and hospital pharmacists. The bags are widely used in hospitals.
The problem is the result of higher demand for IV fluids in the last month due to a bad flu season and production problems caused by holiday closures of factories, USA Today reported.
Eighty to 90 percent of all hospital patients are given IV saline at some point during their stay, noted Dean Parry, director of clinical pharmacy programs for Geisinger Health System in Pennsylvania. It’s the nation’s largest rural health services organization.
The shortage — which has led to huge leaps in prices for saline IV bags — began around the end of the first week in January but appears to improving now, Parry told USA Today.
An FDA spokesman said the agency recognizes there is a problem and is doing what it can.
Copyright © 2024 HealthDay. All rights reserved.